Evidence map›Paper›PMID 38938771›Full record

ArticleJournal of extracellular biology2022

Active antithrombin glycoforms are selectively physiosorbed on plasma extracellular vesicles.

Annalisa Radeghieri, Silvia Alacqua, Andrea Zendrini, Vanessa Previcini, Francesca Todaro, Giuliana Martini, Doris Ricotta, Paolo Bergese

Erratum issuedAbstract read
In one paragraph

Article in Journal of extracellular biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Osmotic Remodeling of Extracellular Vesicles for Precision Nanomedicine.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Annalisa RadeghieriDepartment of Molecular and Translational Medicine University of Brescia Brescia Italy.ORCID https://orcid.org/0000-0003-2737-1090
Silvia AlacquaDepartment of Molecular and Translational Medicine University of Brescia Brescia Italy.
Andrea ZendriniDepartment of Molecular and Translational Medicine University of Brescia Brescia Italy.
Vanessa PreviciniDepartment of Molecular and Translational Medicine University of Brescia Brescia Italy.
Francesca TodaroDepartment of Molecular and Translational Medicine University of Brescia Brescia Italy.
Giuliana MartiniClinical Chemistry Laboratory Spedali Civili Hospital Brescia Italy.
Doris RicottaDepartment of Molecular and Translational Medicine University of Brescia Brescia Italy.
Paolo BergeseDepartment of Molecular and Translational Medicine University of Brescia Brescia Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antithrombin (AT) is a glycoprotein produced by the liver and a principal antagonist of active clotting proteases. A deficit in AT function leads to AT qualitative deficiency, challenging to diagnose. Here we report that active AT may travel physiosorbed on the surface of plasma extracellular vesicles (EVs), contributing to form the "EV-protein corona." The corona is enriched in specific AT glycoforms, thus suggesting glycosylation to play a key role in AT partitioning between EVs and plasma. Differences in AT glycoform composition of the corona of EVs separated from plasma of healthy and AT qualitative deficiency-affected subjects were also noticed. This suggests deconstructing the plasma into its nanostructured components, as EVs, could suggest novel directions to unravel pathophysiological mechanisms.

Indexed as

antithrombinextracellular vesiclesglycosylationprotein corona

Identifiers

PMID38938771
PMCPMC11080738

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.